Table 3.

Individual novelty preference scores for all color trials for each subject

	Delay at 1.5 months				Delay at 6 months				Delay at 18 months
	10 s	30 s	60 s	120 s	10 s	30 s	60 s	120 s	10 s	30 s	60 s	120 s
Group Neo-C
Neo-C-1	68.2	77.4	60.7	63.9	82.8	79.1	83.0	79.1	72.6	79.5	77.5	79.2
Neo-C-2	71.5	64.0	62.4	66.8	81.4	76.4	75.6	79.9	73.5	74.4	74.0	68.1
Neo-C-3	56.9	65.5	73.2	54.1	67.4	80.8	69.9	72.9	74.3	70.5	69.2	62.0
Neo-C-4	63.0	65.7	59.6	62.5	61.7	69.8	67.1	75.6	75.6	69.2	71.9	65.0
Neo-C-5	63.1	67.7	73.4	75.0	76.3	69.6	71.9	76.1	73.3	56.1	61.0	54.5
Neo-C-6	58.8	72.6	65.6	63.1	60.9	73.8	55.9	62.1	72.6	62.5	59.6	61.8
Average	63.6	68.8	65.8	64.2	71.7	74.9	70.6	74.3	73.7	68.7	68.9	65.1
SEM	2.2	2.1	2.5	2.8	4.0	1.9	3.7	2.7	0.5	3.4	2.9	3.4
Group Neo-Hibo
Neo-Hibo-1	64.0	61.5	78.3	63.1	75.7	71.9	63.1	76.3	60.2	57.5	73.6	58.1
Neo-Hibo-2	59.3	70.7	63.9	56.1	71.2	74.8	68.7	76.6	78.0	67.2	76.6	58.1
Neo-Hibo-3	67.7	70.1	57.5	63.9	65.9	77.7	73.6	76.8	62.9	68.9	69.2	55.4
Neo-Hibo-4	56.1	59.7	68.0	65.4	63.7	71.1	75.4	69.3	71.1	63.2	77.8	55.6
Neo-Hibo-5	59.9	62.1	56.5	59.9	62.2	82.8	63.5	67.2	59.0	63.1	61.4	53.7
Average	61.4	64.8	64.8	61.7	67.7	75.7	68.9	73.3	66.3	64.0	71.8	56.2
SEM	2.0	2.3	4.0	1.7	2.5	2.1	2.5	2.1	3.6	2.0	3.0	0.9